Figure 1
From: Hemopexin induces neuroprotection in the rat subjected to focal cerebral ischemia
Regional cerebral blood flow of ischemic hemisphere during MCAO surgery. Control animals suffered from middle cerebral artery occlusion (MCAO) without any treatment; others received an intracerebroventricular injection with vehicle (0.1% sodium azide) or HPX at the following doses: 0.46 mg/ml (low dose), 0.93 mg/ml (middle dose) and 1.86 mg/ml (high dose). Data are expressed as mean±SEM.